| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a88b8ec09e31a28046ea82a2ee8b3e72
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_726222ec803346621bd7e5f979bdd6e7
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a597824fdd0b54817722a0f1a07ec3ee |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-522
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y02A50-30 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N9-1223
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N9-1247
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N9-1092
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N9-1205
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-255
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N1-36
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-0275 |
| classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12R1-42
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12R1-01
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12R1-365
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12R1-32
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-118
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-74
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N1-36 |
| filingDate |
2010-01-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_57d2adf4d6372235accdf42727a114bd
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b35dbc85383ebcbf009200053a07a7b2 |
| publicationDate |
2010-07-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2010084350-A1 |
| titleOfInvention |
Mutant pathogenic bacterial and live attenuated vaccine compositions |
| abstract |
The invention relates to a mutant pathogenic bacterium, preferably a mutant intracellular pathogenic bacterium, that is incapable of expressing one or more metabolic genes; preferably the mutant pathogenic bacterium is attenuated. A mutant pathogenic bacterium of the invention may be incapable of expressing two or more metabolic genes, which encode proteins involved in the same or in different metabolic pathways, such as glycolysis and sugar transport. The invention also relates to vaccines comprising a live attenuated mutant pathogenic bacterium of the invention, methods for their production and their use for the protection of humans or animals against infection with a pathogenic bacterium or against the pathogenic effects of infection. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2015103104-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10351606-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-113088454-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9868769-B2 |
| priorityDate |
2009-01-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |